Prospective Multicenter Study on Clinical Application of Sonazoid in Liver Tumor - Trial NCT04563897
Access comprehensive clinical trial information for NCT04563897 through Pure Global AI's free database. This phase not specified trial is sponsored by Chinese PLA General Hospital and is currently Not yet recruiting. The study focuses on Ultrasound. Target enrollment is 1300 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Chinese PLA General Hospital
Timeline & Enrollment
N/A
Oct 01, 2020
Aug 01, 2021
Primary Outcome
Diagnostic performance of contrast-enhanced ultrasound in different liver background and liver turmors by sonazoid
Summary
Sonazoid as a new generation of ultrasound contrast agent.This study based on the features of
 Sonazoid specific angiography and his mechanical index, the role of Sonazoidin in the
 differential diagnosis of benign and malignant focal liver lesions in different liver
 background was explored
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04563897
Non-Device Trial